Latest Distributions News

ReNerve Limited has entered a strategic partnership with Berkeley Biologics to develop and commercialise two new tissue-based product ranges, aiming to expand its footprint in the US surgical market by the end of 2025.

National Australia Bank has updated key details on its 2025 interim dividend, including dividend reinvestment and bonus security plans, setting clear terms for shareholders ahead of the July payment.

Resimac Group Ltd has announced a special fully franked dividend of AUD 0.12 per share, signaling strong shareholder returns ahead of the mid-year payment date.

CD Private Equity Fund II reported a steep decline in net profit for FY25, with earnings per unit plunging 98%, yet continued to deliver solid distributions to unitholders amid a challenging US private equity market.

CD Private Equity Fund III reported a remarkable 726.6% jump in net profit to $18.56 million for FY25, driven by strong fair value gains and portfolio realizations. The Fund declared a $0.20 per unit distribution amid ongoing geopolitical and market challenges.

CD Private Equity Fund I reported a 43% decline in net profit for FY25 but maintained steady distributions, underpinned by key portfolio exits and a resilient US private equity market.

Ballard Mining Limited is launching an IPO to raise up to $30 million, aiming to accelerate exploration and development of its Mt Ida Gold Project in Western Australia, which hosts over 1.1 million ounces of gold.

Delta Lithium Limited has announced a proposed demerger involving an in-specie distribution of over 63 million Ballard Mining shares to eligible shareholders, pending approval at a June 30 meeting. This move will reduce Delta's stake in Ballard and set the stage for Ballard's eventual ASX listing.

Betashares Capital Ltd has announced the final distribution amounts for May 2025 for a suite of 16 ETFs listed on the ASX AQUA market, all franked and eligible for reinvestment via the Distribution Reinvestment Plan.

Credit Intelligence Ltd is set to return up to AU$1 million to shareholders following the sale of a significant asset, pending shareholder approval and completion of the disposal.

Merchant House International Limited reported a 38% reduction in net loss for FY2025, driven by asset sales and operational wind-down. The company is moving towards divesting remaining assets, delisting from ASX, and winding up.

Little Green Pharma Ltd has reported a robust turnaround for FY2025, posting a $3.3 million profit after tax on revenues up 43%, driven by strong growth in Australia and Europe and strategic acquisitions.